Category Archives: IP Rights

Human Rights Council (2019): Core Group circulates zero draft on access to medicines and vaccines

Source: KEI 26th June, 2019   At the 41st session (24 June 2019 – 12 July 2019) of the Human Rights Council, a bloc of countries known as the the Core Group (Brazil, Egypt, Indonesia, India, Senegal, South Africa and Thailand) … Continue reading

Posted in Access to Medecines, IP Rights, Transparency | Leave a comment

At $2.1 million, newly approved Novartis gene therapy will be world’s most expensive drug

Source: Statnews 27th May, 2019   The Food and Drug Administration on Friday approved the first gene therapy for a type of spinal muscular atrophy, a lifesaving treatment for infants that will also be the most expensive drug in the world. … Continue reading

Posted in Gene Therapy, Novartis Case | Leave a comment

WHA72: Portuguese Minister of Health, Marta Temido, underscores strong support for the WHO transparency resolution

Source: Keionline 22nd May, 2019   On Monday, 20 May 2019, the Republic of Korea, Italy, Costa Rica, Greece, Indonesia, Italy, Mexico, Mongolia, Netherlands, Portugal, Republic of Korea, Saudi Arabia, Spain, and Vietnam convened an official side event at the 72nd … Continue reading

Posted in Access to Medecines, IP Rights, Transparency | Leave a comment

Reminder! Register for panel event WHA72 Friday , 24 May on CART and CRISPR

Source: Keionline 21st May, 2019   24 May 2019- KEI panel discussion- Assessing the implications of the development of new cell and gene-based therapies (including CART and CRISPR): What role should WHO play? On Friday, 24 May 2019, Knowledge Ecology International … Continue reading

Posted in Access to Medicins, IP Rights, Upcoming events | Leave a comment

Intellectual Property rules stand amended

Source: The Hindu | July 02, 2018 Some powers with Customs revoked The Union Ministry of Finance has amended Intellectual Property rules to revoke the power vested with Customs authorities to seize imported products based on complaints of patent infringement. … Continue reading

Posted in IPR Enforcement, IPR policy, Patent infringement | Leave a comment

Five years after the Indian Supreme Court’s novartis verdict

Source: Intellectual Property Watch | May 21, 2018 On 1 April 2013, in a packed room inside India’s Supreme Court, a magnificent building in Indo-British architectural style, two judges delivered a verdict that impacted the national and global conversation about … Continue reading

Posted in Novartis Case, Sec 3 (d) | Leave a comment

Monsanto Can’t Have Patent on Bt Cotton in India, Court Says

Source: Bloomberg | April 11, 2018 Monsanto Co., the world’s largest seed company, can’t own a patent over genetically modified cotton seeds in India, a court ruled on Wednesday. The Delhi High Court verdict said that certain items such as … Continue reading

Posted in Court Cases, Patent, Patents | Leave a comment